Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response.

Cuesta-Sancho, SaraMarquez-Coello, MercedesIllanes-Alvarez, FranciscoMarquez-Ruiz, DenisseArizcorreta, AnaGalan-Sanchez, FatimaMontiel, NataliaRodriguez-Iglesias, ManuelGiron-Gonzalez, Jose-Antonio2023-05-032023-05-03202-12-09Cuesta-Sancho S, Márquez-Coello M, Illanes-Álvarez F, Márquez-Ruiz D, Arizcorreta A, Galán-Sánchez F, et al. Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response. World J Hepatol. 2022 Jan 27;14(1):62-791948-5182http://hdl.handle.net/10668/21634Loss of follow-up or reinfections hinder the expectations of hepatitis C eradication despite the existence of highly effective treatments. Moreover, the elimination of the infection does not imply the reversion of those chronic alterations derived from the previous infection by hepatitis C virus (HCV). This review analyzes the risk factors associated with loss to follow-up in diagnosis or treatment, and the possibility of reinfection. Likewise, it assesses the residual alterations induced by chronic HCV infection considering the liver alterations (inflammation, fibrosis, risk of decompensation, hepatocellular carcinoma, liver transplantation) and, on the other hand, the comorbidities and extrahepatic manifestations (cryoglobulinemia, non-Hodgkin lymphoma, peripheral insulin resistance, and lipid, bone and cognitive alterations). Peculiarities present in subjects coinfected with human immunodeficiency virus are analyzed in each section.enAttribution-NonCommercial 4.0 Internationalhttp://creativecommons.org/licenses/by-nc/4.0/Cirrhosis decompensationDirect antiviral agentsExtrahepatic complicationsHepatitis C virusHepatocarcinomaHuman immunodeficiency virusSustained virological responseLiver transplantationHepacivirusCarcinoma, hepatocellularReinfectionInsulinHIVInsulin resistanceCoinfectionCryoglobulinemiaHepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response.research article35126840open accessCarcinoma hepatocelularCoinfecciónInsulinaReinfecciónResistencia a la insulinaTrasplante de hígadoVIH10.4254/wjh.v14.i1.62PMC8790402https://doi.org/10.4254/wjh.v14.i1.62https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790402/pdf